These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inorganic nanoparticles for cancer imaging and therapy. Huang HC, Barua S, Sharma G, Dey SK, Rege K. J Control Release; 2011 Nov 07; 155(3):344-57. PubMed ID: 21723891 [Abstract] [Full Text] [Related]
3. A review of NIR dyes in cancer targeting and imaging. Luo S, Zhang E, Su Y, Cheng T, Shi C. Biomaterials; 2011 Oct 07; 32(29):7127-38. PubMed ID: 21724249 [Abstract] [Full Text] [Related]
4. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Cheon J, Lee JH. Acc Chem Res; 2008 Dec 07; 41(12):1630-40. PubMed ID: 18698851 [Abstract] [Full Text] [Related]
5. Promising approaches in using magnetic nanoparticles in oncology. Mikhaylov G, Vasiljeva O. Biol Chem; 2011 Nov 07; 392(11):955-60. PubMed ID: 21848508 [Abstract] [Full Text] [Related]
6. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy. Alberti C. Eur Rev Med Pharmacol Sci; 2012 Dec 07; 16(14):1925-33. PubMed ID: 23242718 [Abstract] [Full Text] [Related]
9. Magnetic and fluorescent graphene for dual modal imaging and single light induced photothermal and photodynamic therapy of cancer cells. Gollavelli G, Ling YC. Biomaterials; 2014 May 07; 35(15):4499-507. PubMed ID: 24602568 [Abstract] [Full Text] [Related]
10. Biomedical nanomaterials for imaging-guided cancer therapy. Huang Y, He S, Cao W, Cai K, Liang XJ. Nanoscale; 2012 Oct 21; 4(20):6135-49. PubMed ID: 22929990 [Abstract] [Full Text] [Related]
11. 'Two is better than one'--probes for dual-modality molecular imaging. Jennings LE, Long NJ. Chem Commun (Camb); 2009 Jun 28; (24):3511-24. PubMed ID: 19521594 [Abstract] [Full Text] [Related]
12. Combined PET/MRI: one step further in multimodality imaging. Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ. Trends Mol Med; 2010 Nov 28; 16(11):508-15. PubMed ID: 20851684 [Abstract] [Full Text] [Related]
13. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Wunder A, Straub RH, Gay S, Funk J, Müller-Ladner U. Rheumatology (Oxford); 2005 Nov 28; 44(11):1341-9. PubMed ID: 15972356 [Abstract] [Full Text] [Related]
14. Nanoparticles for bioimaging. Sharma P, Brown S, Walter G, Santra S, Moudgil B. Adv Colloid Interface Sci; 2006 Nov 16; 123-126():471-85. PubMed ID: 16890182 [Abstract] [Full Text] [Related]
15. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics. Benyettou F, Lalatonne Y, Chebbi I, Di Benedetto M, Serfaty JM, Lecouvey M, Motte L. Phys Chem Chem Phys; 2011 Jun 07; 13(21):10020-7. PubMed ID: 21409252 [Abstract] [Full Text] [Related]
16. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Rappeport ED, Loft A. Abdom Imaging; 2007 Jun 07; 32(5):624-34. PubMed ID: 17710359 [Abstract] [Full Text] [Related]
17. Translational imaging of lymphatics in cancer. Cohen SM, Fishinghawk BG, Cohen MS. Adv Drug Deliv Rev; 2011 Sep 10; 63(10-11):956-62. PubMed ID: 21683745 [Abstract] [Full Text] [Related]
20. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Al-Jamal WT, Kostarelos K. Acc Chem Res; 2011 Oct 18; 44(10):1094-104. PubMed ID: 21812415 [Abstract] [Full Text] [Related] Page: [Next] [New Search]